- Home
- NMZ vs ATAI Comparison
NMZ vs ATAI Comparison
Compare NMZ & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMZ | ATAI |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NMZ | ATAI |
|---|---|---|
| Price | $10.62 | $3.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $13.86 |
| AVG Volume (30 Days) | 356.8K | ★ 3.9M |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,018,000.00 |
| Revenue This Year | N/A | $956.49 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 811.78 |
| 52 Week Low | $8.26 | $1.15 |
| 52 Week High | $11.14 | $6.75 |
Technical Indicators
Market Signals| Indicator | NMZ | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 51.51 |
| Support Level | $10.50 | $3.32 |
| Resistance Level | $10.57 | $3.98 |
| Average True Range (ATR) | 0.08 | 0.23 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 90.48 | 69.42 |
Price Performance
Historical ComparisonAbout NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.